Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sedative effect of remimazolam combined with alfentanil in colonoscopic polypectomy
ChiCTR2100046492Phase 4Not yet recruiting
- Sponsor
- Tongji Hospital
- Start
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remimazolam in colonic polyp (4 arms), sponsored by Tongji Hospital. Primary endpoint: Sedation score. Planned start Jun 2021; status: not yet recruiting.
02
Drugs
remimazolam
03
Conditions
colonic polyp
Beyond the preview
Go deeper on ChiCTR2100046492.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100046492.